Akebia Therapeutics is in a volatile biotech sector, often subject to significant fluctuations based on clinical trial results and regulatory decisions. It's crucial to consider recent FDA updates on their drug applications and any partnerships or licensing agreements they have. Keep an eye on their financial health, focusing on R&D spending and cash reserves. Biotech investments can be high-risk, high-reward, so ensure it fits your risk tolerance. Have you checked any recent developments or upcoming earnings reports?
